Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("anaplastic thyroid cancer")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Antiproliferative Effect of Chrysin on Anaplastic Thyroid CancerB, Tramanh Phan; YU, Xiao-Min; KUNNIMALAIYAAN, Muthusamy et al.The Journal of surgical research (Print). 2011, Vol 170, Num 1, pp 84-88, issn 0022-4804, 5 p.Article

Marginal Treatment Benefit in Anaplastic Thyroid CancerHAYMART, Megan R; BANERJEE, Mousumi; HUIYING YIN et al.Cancer. 2013, Vol 119, Num 17, pp 3133-3139, issn 0008-543X, 7 p.Article

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological informationMONTERO-CONDE, C; MARTIN-CAMPOS, J. M; ROBLEDO, M et al.Oncogene (Basingstoke). 2008, Vol 27, Num 11, pp 1554-1561, issn 0950-9232, 8 p.Article

Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivoCATALANO, Maria Graziella; PUGLIESE, Mariateresa; MAININI, Franco et al.International journal of cancer (Print). 2012, Vol 130, Num 3, pp 694-704, issn 0020-7136, 11 p.Article

The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cellsMANDAL, M; KIM, S; YOUNES, M. N et al.British journal of cancer. 2005, Vol 92, Num 10, pp 1899-1905, issn 0007-0920, 7 p.Article

Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancerAKAISHI, Junko; ONDA, Masamitsu; ASAKA, Shinichi et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4437-4442, issn 0250-7005, 6 p.Article

Metastatic anaplastic carcinoma of the thyroid mimicking squamous cell carcinoma : Report of a case of a challenging cytologic diagnosisOKTAY, Maja H; SMOLKIN, Matthew B; WILLIAMS, Mark et al.Acta cytologica. 2006, Vol 50, Num 2, pp 201-204, issn 0001-5547, 4 p.Article

Thyroid cancer review 3 : management of medullary and undifferentiated thyroid cancerNIX, P. A; NICOLAIDES, A; COATESWORTH, A. P et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 1, pp 80-84, issn 1368-5031, 5 p.Article

Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovory of its expression inhibits cell growthONDA, M; AKAISHI, J; ASAKA, S et al.British journal of cancer. 2005, Vol 92, Num 12, pp 2216-2224, issn 0007-0920, 9 p.Article

Anaplastic thyroid cancerO'NEILL, James Paul; SHAHA, Ashok R.Oral oncology (1997). 2013, Vol 49, Num 7, pp 702-706, issn 1368-8375, 5 p.Article

ACR Appropriateness Criteria® thyroid carcinomaSALAMA, Joseph K; GOLDEN, Daniel W; WORDEN, Francis et al.Oral oncology (1997). 2014, Vol 50, Num 6, pp 577-586, issn 1368-8375, 10 p.Article

In vivo evidence of duality effects for lovastatin in a nude mouse cancer modelWANG, Chih-Yuan; SHUI, Hao-Ai; CHANG, Tien-Chun et al.International journal of cancer (Print). 2009, Vol 126, Num 2, pp 578-582, issn 0020-7136, 5 p.Article

Gefitinib (Iressa) Potentiates the Effect of Ionizing Radiation in Thyroid Cancer Cell LinesLOPEZ, Jay Patrick; WANG-RODRIGUEZ, Jessica; CHANG, Catherine Y et al.The Laryngoscope. 2008, Vol 118, Num 8, pp 1372-1376, issn 0023-852X, 5 p.Article

Radioiodide imaging and treatment of ARO cancer xenograft in a mousel model after expression of human sodium iodide symporterHSIEH, Ya-Ju; KE, Chien-Chih; LIU, Ren-Shyan et al.Anticancer research. 2007, Vol 27, Num 4B, pp 2515-2522, issn 0250-7005, 8 p.Article

Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancerAKAISHI, J; ONDA, M; OKAMOTO, J et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 4, pp 213-218, issn 0171-5216, 6 p.Article

Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystinTAE HYUN KIM; YOUNG HYUN YOO; KANG, Do-Young et al.International journal of oncology. 2009, Vol 34, Num 5, pp 1353-1362, issn 1019-6439, 10 p.Article

Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinibGRAZIELLA CATALANO, Maria; PUGLIESE, Mariateresa; POLI, Roberta et al.Oncology reports. 2009, Vol 21, Num 2, pp 515-521, issn 1021-335X, 7 p.Article

Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cellsSUNG HWA CHUNG; ONODA, Naoyoshi; ISHIKAWA, Tetsuro et al.Japanese journal of cancer research. 2002, Vol 93, Num 12, pp 1358-1365, issn 0910-5050, 8 p.Article

Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinomaWISEMAN, Sam M; GRIFFITH, Obi L; GOWN, Allen et al.The American journal of surgery. 2011, Vol 201, Num 5, pp 578-584, issn 0002-9610, 7 p.Conference Paper

Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinomaWISEMAN, Sam M; GRIFFITH, Obi L; GOWN, Allen et al.The American journal of surgery. 2011, Vol 201, Num 5A, pp 580-586, issn 0002-9610, 7 p.Article

A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancersCOHEN, Stephanie M; MUKERJI, Ridhwi; TIMMERMANN, Barbara N et al.The American journal of surgery. 2012, Vol 204, Num 6, pp 895-900, issn 0002-9610, 6 p.Article

Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cellsKUREBAYASHI, Junichi; OKUBO, Sumiko; YAMAMOTO, Yutaka et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 4, pp 460-470, issn 0344-5704, 11 p.Article

Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathwayZHONG, Wen-Bin; HSU, Sung-Po; HO, Pei-Yin et al.Biochemical pharmacology. 2011, Vol 82, Num 11, pp 1663-1672, issn 0006-2952, 10 p.Article

Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinomaPRICHARD, Christopher N; KIM, Seungwon; YAZICI, Yasmin D et al.The Laryngoscope. 2007, Vol 117, Num 4, pp 674-679, issn 0023-852X, 6 p.Article

  • Page / 1